John Kilcoyne

John Kilcoyne

Lake Forest-based ReVision Optics Inc. has shut down saying, “it is with regret, that we have to close our doors.” The ophthalmic device company makes the Raindrop Near Vision Inlay, a replacement eye lens used in the surgical correction of age-related farsightedness.

Revision raised $32 million in equity financing in November 2016. Proceeds from the round, which was led by Johnson & Johnson Development Corp., were said to support expansion of U.S. commercialization. Raindrop received Food and Drug Administration approval in June.

Chief Executive John Kilcoyne declined comment.

The company was founded in 1996 and changed its name to ReVision in 2005.